Meratran with reserpine; adjunctive use in the treatment of Parkinson's disease.
D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000628:therapy*; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D046948:Secologanin Tryptamine Alkaloids; D012110:Reserpine
ANALEPTICS/therapeutic use; PARALYSIS AGITANS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use